Related Experiment Video
Updated: Apr 5, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Governing the research-care divide in clinical biobanking: Dutch perspectives
Martin Boeckhout1, Conor M W Douglas
1BBMRI-NL, Department of Human Genetics, Leiden University Medical Centre, PO Box 9600, 2300 RC, Leiden, The Netherlands, martin@boeckhout.nl.
Abstract:
Biobanking, the large-scale, systematic collection of data and tissue for open-ended research purposes, is on the rise, particularly in clinical research. The infrastructures for the systematic procurement, management and eventual use of human tissue and data are positioned between healthcare and research. However, the positioning of biobanking infrastructures and transfer of tissue and data between research and care is not an innocuous go-between. Instead, it involves changes in both domains and raises issues about how distinctions between research and care are drawn and policed. Based on an analysis of the emergence and development of clinical biobanking in the Netherlands, this article explores how processes of bio-objectification associated with biobanking arise, redefining the ways in which distinctions between research and clinical care are governed.
Related Concept Videos
Ethics in Research
Ethics and Bioethics
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Bioequivalence studies: Biowaivers
Ethical Issues
Ethical Concerns in Healthcare:

